IL33 and pulmonary fibrosis: Xie and colleagues recently showed that BM-MSC-Exo-sourced miR-214 inhibited progression of bleomycin-induced pulmonary fibrosis by suppressing the IL-33/ST2 axis in fibrotic lungs [56].